PHILADELPHIA, Sept. 6, 2022 /PRNewswire/ — Clincierge CEO Scott Gray has been named to the PharmaVoice 100, an annual list recognizing the most inspiring people in life sciences.
Clincierge CEO Scott Gray Named to PharmaVoice 100 Read More »
PHILADELPHIA, July 5, 2022 – Titan CEO and headline sponsor Wipfli LLP are pleased to announce the 2022 Philadelphia Titan 100. The Titan 100 program recognizes Philadelphia’s Top 100 CEO’s & C-level executives. They are the area’s most accomplished business leaders in their industry using criteria that includes demonstrating exceptional leadership, vision, and passion.
Scott Gray Named 2022 Philadelphia Titan 100 Read More »
Featured in Clinical Researcher: Scott Gray, CEO discusses the importance of a hybrid approach to decentralized trials for patients with rare diseases.
A Hybrid Approach to Decentralized Trials Read More »
Featured on CenterWatch.com: Newly published results from a survey, conducted by the patient support service company Clincierge, found that 95 percent of the trial participants responded and 98 percent of their caregivers considered it essential to have a single point of contact to help them throughout a trial, especially when arranging travel plans.
Rare Disease Trial Participants Need Extra Support and Assistance, Survey Shows Read More »
Featured on ACRPnet.org: Looking for ways to increase participation in your clinical trials? First, stop calling participants “subjects,” says Scott Gray, CEO of Clincierge, whose organization just released a research report, “Voice of the Patient,” examining the patient experience in clinical trials of rare diseases. “They are volunteers, they are human beings,” Gray says.
Practical Tips to Boost Clinical Trial Participation and Retention Read More »
PHILADELPHIA and SAN DIEGO, June 14, 2022 /PRNewswire/ — Clincierge today released “Voice of the Patient,” a research report examining the patient experience in clinical trials of rare diseases, at the 2022 BIO International Convention in San Diego, California.
Clincierge Releases Study on Patient Experience in Clinical Trials Read More »
Featured in Drug Discovery World: DDW’s Reece Armstrong speaks to Scott Gray, President & CEO of Clincierge about its unique approach to improving the clinical trial experience for patients.
The Company Bringing Patients to Clinical Trials Read More »
During BIO International, a group of industry experts discussed patient recruitment and retention challenges in the panel discussion Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials on Monday, June 13. Outsourcing-Pharma spoke with Clincierge CEO Scott Gray, the moderator of the talk, to get a sneak peek at the session.
BIO Panel Takes on Patient Recruitment, Retention Challenges Read More »
Featured in The Science Advisory Board: Patient recruitment and retention are among the biggest challenges facing clinical research, particularly in studies targeting rare diseases that have a limited pool of patients, contends Clincierge CEO Scott Gray. At the 2022 Biotechnology Innovation Organization (BIO) International Convention, Clincierge will release the results of an independent, institutional review
The ‘Voice of the Patient’ Needs to be Heard in Clinical Trials: Study Read More »
PHILADELPHIA, June 2, 2022 /PRNewswire/ — Clincierge today announced CEO Scott Gray will moderate Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials at the upcoming 2022 BIO International Convention on June 13-16, 2022, in San Diego, California.
Clincierge to Host Patient Experience Panel at BIO International 2022 Read More »
